Pharmaceutical Business review

Aurobindo obtains manufacturing approval for Quinapril tablets

Quinapril Tablets USP 5mg, 10mg, 20mg and 40mg is the generic version of Pfizer Pharmaceuticals’ Accupril Tablets 5mg, 10mg, 20mg and 40mg respectively.

The product that falls under the cardiovascular (CVS) therapeutic category has been indicated for the treatment of hypertension.

The US regulator approved the product out of Unit VII (SEZ) formulations facility in Hyderabad, India.

Indian-based Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients in facilities
approved by several regulatory agencies like USFDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil.